Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Overview of in vivo and ex vivo endpoints in murine food allergy models: Suitable for evaluation of the sensitizing capacity of novel proteins

L. Castan, KL. Bøgh, NZ. Maryniak, MM. Epstein, S. Kazemi, L. O'Mahony, M. Bodinier, JJ. Smit, JHM. van Bilsen, C. Blanchard, R. Głogowski, H. Kozáková, M. Schwarzer, M. Noti, N. de Wit, G. Bouchaud, S. Bastiaan-Net

. 2020 ; 75 (2) : 289-301. [pub] 20190709

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012875

Significant efforts are necessary to introduce new dietary protein sources to feed a growing world population while maintaining food supply chain sustainability. Such a sustainable protein transition includes the use of highly modified proteins from side streams or the introduction of new protein sources that may lead to increased clinically relevant allergic sensitization. With food allergy being a major health problem of increasing concern, understanding the potential allergenicity of new or modified proteins is crucial to ensure public health protection. The best predictive risk assessment methods currently relied on are in vivo models, making the choice of endpoint parameters a key element in evaluating the sensitizing capacity of novel proteins. Here, we provide a comprehensive overview of the most frequently used in vivo and ex vivo endpoints in murine food allergy models, addressing their strengths and limitations for assessing sensitization risks. For optimal laboratory-to-laboratory reproducibility and reliable use of predictive tests for protein risk assessment, it is important that researchers maintain and apply the same relevant parameters and procedures. Thus, there is an urgent need for a consensus on key food allergy parameters to be applied in future food allergy research in synergy between both knowledge institutes and clinicians.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012875
003      
CZ-PrNML
005      
20210507101543.0
007      
ta
008      
210420s2020 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/all.13943 $2 doi
035    __
$a (PubMed)31187876
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Castan, Laure $u INRA, UR 1268 BIA Nantes, Nantes, France
245    10
$a Overview of in vivo and ex vivo endpoints in murine food allergy models: Suitable for evaluation of the sensitizing capacity of novel proteins / $c L. Castan, KL. Bøgh, NZ. Maryniak, MM. Epstein, S. Kazemi, L. O'Mahony, M. Bodinier, JJ. Smit, JHM. van Bilsen, C. Blanchard, R. Głogowski, H. Kozáková, M. Schwarzer, M. Noti, N. de Wit, G. Bouchaud, S. Bastiaan-Net
520    9_
$a Significant efforts are necessary to introduce new dietary protein sources to feed a growing world population while maintaining food supply chain sustainability. Such a sustainable protein transition includes the use of highly modified proteins from side streams or the introduction of new protein sources that may lead to increased clinically relevant allergic sensitization. With food allergy being a major health problem of increasing concern, understanding the potential allergenicity of new or modified proteins is crucial to ensure public health protection. The best predictive risk assessment methods currently relied on are in vivo models, making the choice of endpoint parameters a key element in evaluating the sensitizing capacity of novel proteins. Here, we provide a comprehensive overview of the most frequently used in vivo and ex vivo endpoints in murine food allergy models, addressing their strengths and limitations for assessing sensitization risks. For optimal laboratory-to-laboratory reproducibility and reliable use of predictive tests for protein risk assessment, it is important that researchers maintain and apply the same relevant parameters and procedures. Thus, there is an urgent need for a consensus on key food allergy parameters to be applied in future food allergy research in synergy between both knowledge institutes and clinicians.
650    _2
$a zvířata $7 D000818
650    _2
$a tělesná teplota $7 D001831
650    _2
$a cytokiny $x biosyntéza $7 D016207
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a potravinová alergie $x krev $x imunologie $7 D005512
650    _2
$a imunoglobulin E $x krev $7 D007073
650    _2
$a imunoglobulin G $x krev $7 D007074
650    _2
$a myši $7 D051379
650    _2
$a inbrední kmeny myší $7 D008815
650    _2
$a fenotyp $7 D010641
650    _2
$a T-lymfocyty $x imunologie $7 D013601
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bøgh, Katrine L $u National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
700    1_
$a Maryniak, Natalia Z $u National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
700    1_
$a Epstein, Michelle M $u Experimental Allergy Laboratory, Department of Dermatology, Medical University of Vienna, Vienna, Austria
700    1_
$a Kazemi, Sahar $u Experimental Allergy Laboratory, Department of Dermatology, Medical University of Vienna, Vienna, Austria
700    1_
$a O'Mahony, Liam $u Department of Medicine, APC Microbiome Ireland, National University of Ireland, Cork, Ireland $u Department of Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland
700    1_
$a Bodinier, Marie $u INRA, UR 1268 BIA Nantes, Nantes, France
700    1_
$a Smit, Joost J $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
700    1_
$a van Bilsen, Jolanda H M $u TNO, Zeist, The Netherlands
700    1_
$a Blanchard, Carine $u Consultant, London, UK
700    1_
$a Głogowski, Robert $u Department of Animal Breeding and Production, Warsaw University of Life Sciences, Warsaw, Poland
700    1_
$a Kozáková, Hana $u Institute of Microbiology, Czech Academy of Sciences, Nový Hrádek, Czech Republic
700    1_
$a Schwarzer, Martin $u Institute of Microbiology, Czech Academy of Sciences, Nový Hrádek, Czech Republic
700    1_
$a Noti, Mario $u Institute of Pathology, University of Bern, Bern, Switzerland
700    1_
$a de Wit, Nicole $u Wageningen Food and Biobased Research, Wageningen, The Netherlands
700    1_
$a Bouchaud, Grégory $u INRA, UR 1268 BIA Nantes, Nantes, France
700    1_
$a Bastiaan-Net, Shanna $u Wageningen Food and Biobased Research, Wageningen, The Netherlands
773    0_
$w MED00009088 $t Allergy $x 1398-9995 $g Roč. 75, č. 2 (2020), s. 289-301
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31187876 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101543 $b ABA008
999    __
$a ok $b bmc $g 1651116 $s 1133254
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 75 $c 2 $d 289-301 $e 20190709 $i 1398-9995 $m Allergy $n Allergy $x MED00009088
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...